Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Icodextrin Effects on Glucose Transporter Activation and Mediators of Fibrosis

NCT02133313 is registered in ClinicalTrials.gov with University of Alabama at Birmingham as lead sponsor.

NCT NCT02133313
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02133313 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Icodextrin Effects on Glucose Transporter Activation and Mediators of Fibrosis
Lead sponsor
University of Alabama at Birmingham
Phase
Observational
Overall status
Completed
Start date
May 31, 2014
Completion date
March 31, 2017
Enrollment
49 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

end stage renal disease